Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.

Celen S, Koole M, De Angelis M, Sannen I, Chitneni SK, Alcazar J, Dedeurwaerdere S, Moechars D, Schmidt M, Verbruggen A, Langlois X, Van Laere K, Andrés JI, Bormans G.

J Nucl Med. 2010 Oct;51(10):1584-91. doi: 10.2967/jnumed.110.077040. Epub 2010 Sep 16.

PMID:
20847170
[PubMed - indexed for MEDLINE]
Free Article
2.

Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.

Tu Z, Xu J, Jones LA, Li S, Mach RH.

Nucl Med Biol. 2010 May;37(4):509-16. doi: 10.1016/j.nucmedbio.2009.12.012. Epub 2010 Mar 6.

PMID:
20447563
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Role of phosphodiesterases in dopamine signal transduction.

Nishi A, Kuroiwa M, Shuto T.

Nihon Yakurigaku Zasshi. 2010 Jan;135(1):8-13. Review. No abstract available.

PMID:
20075564
[PubMed - indexed for MEDLINE]
4.

Patented PDE10A inhibitors: novel compounds since 2007.

Kehler J, Kilburn JP.

Expert Opin Ther Pat. 2009 Dec;19(12):1715-25. doi: 10.1517/13543770903431050. Review.

PMID:
19939189
[PubMed - indexed for MEDLINE]
5.

PDE10A inhibitors: an assessment of the current CNS drug discovery landscape.

Chappie T, Humphrey J, Menniti F, Schmidt C.

Curr Opin Drug Discov Devel. 2009 Jul;12(4):458-67. Review.

PMID:
19562642
[PubMed - indexed for MEDLINE]
6.

The role of phosphodiesterases in schizophrenia : therapeutic implications.

Siuciak JA.

CNS Drugs. 2008;22(12):983-93. doi: 10.2165/0023210-200822120-00002. Review.

PMID:
18998737
[PubMed - indexed for MEDLINE]
7.

Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia.

Menniti FS, Chappie TA, Humphrey JM, Schmidt CJ.

Curr Opin Investig Drugs. 2007 Jan;8(1):54-9. Review.

PMID:
17263185
[PubMed - indexed for MEDLINE]
8.

Role of phosphodiesterases in neurological and psychiatric disease.

Hebb AL, Robertson HA.

Curr Opin Pharmacol. 2007 Feb;7(1):86-92. Epub 2006 Nov 20. Review.

PMID:
17113826
[PubMed - indexed for MEDLINE]
9.

Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase.

Xie Z, Adamowicz WO, Eldred WD, Jakowski AB, Kleiman RJ, Morton DG, Stephenson DT, Strick CA, Williams RD, Menniti FS.

Neuroscience. 2006 May 12;139(2):597-607. Epub 2006 Feb 17.

PMID:
16483723
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature.

Akerman ME, Pilch J, Peters D, Ruoslahti E.

Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2040-5. Epub 2005 Feb 1.

PMID:
15687502
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles.

SUTHERLAND EW, RALL TW.

J Biol Chem. 1958 Jun;232(2):1077-91. No abstract available.

PMID:
13549488
[PubMed - indexed for MEDLINE]
Free Article
12.

Cyclic nucleotide phosphodiesterases.

Essayan DM.

J Allergy Clin Immunol. 2001 Nov;108(5):671-80. Review.

PMID:
11692087
[PubMed - indexed for MEDLINE]
13.

Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A.

Fujishige K, Kotera J, Omori K.

Eur J Biochem. 1999 Dec;266(3):1118-27.

PMID:
10583409
[PubMed - indexed for MEDLINE]
Free Article
14.

Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A).

Fujishige K, Kotera J, Michibata H, Yuasa K, Takebayashi S, Okumura K, Omori K.

J Biol Chem. 1999 Jun 25;274(26):18438-45.

PMID:
10373451
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk